Literature DB >> 19732739

Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.

Ponnusamy Babu1, Balagurunathan Kuberan.   

Abstract

Heparitinase I, a key lyase enzyme essential for structural analysis of heparan sulfate (HS), degrades HS domains that are undersulfated at glucuronyl residues through an elimination mechanism. Earlier studies employed viscosimetric measurements and electrophoresis to deduce the mechanism of action of heparitinase I and two other related lyases, heparitinase II and heparitinase III. However, these findings lack molecular evidence for the intermediates formed and could not distinguish whether the cleavage occurred from the reducing end or the nonreducing end. In the current study, 2-aminoacridone (2-AMAC)-labeled HS precursor oligosaccharides of various sizes were prepared to investigate the mechanism of heparitinase I-mediated depolymerization using sensitive and quantitative methodologies. Furthermore, fluorescent (2-AMAC) tagging of HS precursor oligosaccharides allowed us to distinguish fragments that result from cleavage of the substrates at various time intervals and sites farther away from the reducing and nonreducing ends of oligosaccharide substrates. This study provides the first direct molecular evidence for a predominantly random endolytic mechanism of cleavage of HS precursor oligosaccharides by heparitinase I. This robust strategy can be adapted to deduce the mechanism of action of other heparitinases and also to deduce structural information of complex HS oligosaccharides of biological importance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732739      PMCID: PMC2791463          DOI: 10.1016/j.ab.2009.08.036

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  33 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  The enzymatic degradation of heparin and heparitin sulfate. I. The fractionation of a crude heparinase from flavobacteria.

Authors:  A Linker; P Hovingh
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

4.  The enzymatic degradation of heparitin sulfate. II. Isolation and characterization of non-sulfated oligosaccharides.

Authors:  A Linker; P Hovingh
Journal:  Biochim Biophys Acta       Date:  1968-08-06

5.  The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria.

Authors:  P Hovingh; A Linker
Journal:  J Biol Chem       Date:  1970-11-25       Impact factor: 5.157

6.  Correlation between structure and function of heparin.

Authors:  R D Rosenberg; L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.

Authors:  Balagurunathan Kuberan; Miroslaw Lech; Lijuan Zhang; Zhengliang L Wu; David L Beeler; Robert D Rosenberg
Journal:  J Am Chem Soc       Date:  2002-07-24       Impact factor: 15.419

8.  Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry.

Authors:  Zhenqing Zhang; Jin Xie; Haiying Liu; Jian Liu; Robert J Linhardt
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

9.  Software tool for the structural determination of glycosaminoglycans by mass spectrometry.

Authors:  Bérangère Tissot; Alessio Ceroni; Andrew K Powell; Howard R Morris; Edwin A Yates; Jeremy E Turnbull; John T Gallagher; Anne Dell; Stuart M Haslam
Journal:  Anal Chem       Date:  2008-12-01       Impact factor: 6.986

10.  The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides.

Authors:  Malcolm Lyon; Jon A Deakin; Daniel Lietha; Ermanno Gherardi; John T Gallagher
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

View more
  5 in total

1.  Differential effects of Heparitinase I and Heparitinase III on endothelial tube formation in vitro.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

2.  Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin.

Authors:  Zhongping Xiao; Britney R Tappen; Mellisa Ly; Wenjing Zhao; Lauren P Canova; Huashi Guan; Robert J Linhardt
Journal:  J Med Chem       Date:  2010-12-17       Impact factor: 7.446

3.  Sulfation patterns determine cellular internalization of heparin-like polysaccharides.

Authors:  Karthik Raman; Caitlin Mencio; Umesh R Desai; Balagurunathan Kuberan
Journal:  Mol Pharm       Date:  2013-02-27       Impact factor: 4.939

4.  Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies.

Authors:  Steen U Hansen; Gavin J Miller; Claire Cole; Graham Rushton; Egle Avizienyte; Gordon C Jayson; John M Gardiner
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Glycomics expression analysis of sulfated glycosaminoglycans of human colorectal cancer tissues and non-neoplastic mucosa by electrospray ionization mass spectrometry.

Authors:  Ana Paula Cleto Marolla; Jaques Waisberg; Gabriela Tognini Saba; Daniel Reis Waisberg; Fernando Beani Margeotto; Maria Aparecida da Silva Pinhal
Journal:  Einstein (Sao Paulo)       Date:  2015 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.